https://www.merck.com/news/merck-to-acquire-harpoon-therapeutics-further-diversifying-oncology-pipeline/
Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline - Merck.com
Dec 31, 2025 - Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung...
to acquireharpoon therapeuticsmerckdiversifyingoncology
https://www.biospace.com/harpoon-therapeutics-expands-management-team
Harpoon Therapeutics Expands Management Team - BioSpace
Oct 26, 2017 - Harpoon Therapeutics announced today that it has appointed Susan Dana Jones, Ph.D., to the position of senior vice president, product development and Rachael...
harpoon therapeuticsmanagement teamexpandsbiospace
https://robinhood.com/us/en/stocks/HARP/
Harpoon Therapeutics: HARP Stock Price Quote & News | Robinhood
You can watch HARP and buy and sell other stocks, ETFs, and their options commission-free on Robinhood. Change the date range, see whether others are buying or...
stock price quoteharpoon therapeuticsnewsrobinhood
https://www.merck.com/news/merck-completes-acquisition-of-harpoon-therapeutics-inc/
Merck Completes Acquisition of Harpoon Therapeutics, Inc. - Merck.com
Dec 31, 2025 - Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 (MK-6070), an investigational delta-like ligand 3 (DLL3)...
completes acquisitionharpoon therapeuticsmerckinc